9.4K(top 4%)
articles
233.4K(top 3%)
citations
1,846(top 4%)
★★ articles
64(top 4%)
★★★ articles
2.4(top 22%)
Avg IF
166(top 3%)
H-Index
299(top 3%)
G-Index
2,039
journals

Most Cited Articles of The Ottawa Hospital

TitleJournalYearCitations
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, The20214.5K
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine20173.2K
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsBMJ, The20103.1K
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaLancet Neurology, The20182.4K
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialLancet, The20162.3K
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Critical Care Medicine20171.7K
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factorsClinics in Colon and Rectal Surgery20091.3K
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trialsJournal of Clinical Epidemiology20101.2K
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyLancet Oncology, The20151.2K
Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementPhysical Therapy20091.2K
Scoping reviews: time for clarity in definition, methods, and reportingJournal of Clinical Epidemiology20141.2K
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosisNew England Journal of Medicine20031K
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsInternational Journal of Surgery20121K
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimerAnnals of Internal Medicine2001851
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementiaNature2011846
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trialsPLoS ONE2012741
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialLancet Oncology, The2016691
Validation of a decision regret scaleMedical Decision Making2003687
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviewsBMJ, The2021666
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregiversCmaj2004614
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesNeurology2006601
Decision aids for patients facing health treatment or screening decisions: systematic reviewBMJ: British Medical Journal1999577
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label StudyJAMA Oncology2017572
Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the communityCmaj2010557
Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsisAmerican Journal of Respiratory and Critical Care Medicine2010515